Showing 1,241 - 1,260 results of 101,142 for search '(( 5 ((ppm decrease) OR (a decrease)) ) OR ( 5 ((mm decrease) OR (we decrease)) ))', query time: 1.81s Refine Results
  1. 1241

    Decreased Tks5 expression results in neural crest-derived defects. by Danielle A. Murphy (212554)

    Published 2011
    “…<p>(A–B) Melanophores within the trunk region above the yolk sac extension in control MO-injected and Tks5 MO-injected embryos were qualitatively (A) and quantitatively (B) analyzed. n = 15 embryos and SEM is shown by bar. p values obtained from Student's t-test. ** denotes p<0.01. …”
  2. 1242

    A Peptide Mimetic of 5-Acetylneuraminic Acid-Galactose Binds with High Avidity to Siglecs and NKG2D by Laura L. Eggink (760403)

    Published 2015
    “…Using plant lectins as analogs of lectin-type cell-surface receptors, a tetravalent form of a peptide with the sequence NPSHPLSG, designated svH1C, bound with high avidity to lectins specific for glycans with terminal 5-acetylneuraminic acid (Neu5Ac)-galactose (Gal)/N-acetylgalactosamine (GalNAc) sequences. …”
  3. 1243
  4. 1244

    Supplementary file 1_Role and mechanism of IGFBP5 in the real-ambient particulate matter exposure-induced chronic lung injury.docx by Ningning Chen (509273)

    Published 2025
    “…Moreover, microRNAs (miRNAs) are an important class of gene expression regulators. We found that the upregulated hsa-miR-33a-5p repressed IGFBP5 translation by forming a silencing complex with Argonaute protein 2 (AGO2) in a real-ambient PM exposure system, which further led to the suppression of the ERK1/2-SOD2 signaling pathway and increased levels of ROS.…”
  5. 1245
  6. 1246
  7. 1247
  8. 1248
  9. 1249
  10. 1250
  11. 1251

    Effects of vidarabine, V2E, V3E and V5E on cardiac fibrosis. by Kenji Suita (750993)

    Published 2025
    “…<p>We examined the effects of chronic ISO infusion (60 mg/kg/day for 1 week) via osmotic mini-pumps in WT mice with/without vidarabine (Vida), V2E, V3E or V5E on cardiac fibrosis by means of Masson-trichrome staining. …”
  12. 1252
  13. 1253

    Data_Sheet_1_The Risky Decrease of Fishing Reference Points Under Climate Change.docx by Morgane Travers-Trolet (548023)

    Published 2020
    “…The model was first parameterized and run to fit the historical situation (2000–2009) and then used to assess the ecosystem state for the 2050–2059 period, using two contrasting climate change scenarios (RCP 4.5 and RCP 8.5). For each condition, a monospecific MSY estimation routine was performed by varying species fishing mortality independently and allowed estimation of reference points for each species. …”
  14. 1254

    Increasing blood pressure causes decreased whisker displacement, but higher internal forces at the RS level. by Yifu Luo (10514978)

    Published 2021
    “…From orange to blue, the value of k<sub>3</sub> increases logarithmically from 10<sup>5</sup> to10<sup>6</sup>N/m. With higher blood pressure, r(x) in the RS region decreases. …”
  15. 1255
  16. 1256
  17. 1257
  18. 1258

    RBC ROS production induces Band 3 phosphorylation, decreasing membrane deformability and lipid mobility. by Joseph Khoory (844565)

    Published 2016
    “…RBCs pretreated with buffer or 1 mM GSH-ME in the presence of EMA were then incubated with anti-GPA mAb (E4, 1 μg/mL or R10, 5 μg/mL), IgG control mAb (5 μg/mL, all top left panel), or t-BHP (100 and 200 μM, top right panel). …”
  19. 1259

    Table1_Discontinuation of afterload-reducing drugs decreases left ventricular outflow tract obstruction in hypertrophic obstructive cardiomyopathy.docx by Anselm A. Derda (5866220)

    Published 2024
    “…</p>Results<p>16 patients discontinued their afterload-reducing drugs, resulting in a significant decrease in median LVOT gradient from 86.5 [60.5–109.3] mmHg to 61.5 [28.3–97.50] mmHg (p = 0.0004). …”
  20. 1260

    Table1_Discontinuation of afterload-reducing drugs decreases left ventricular outflow tract obstruction in hypertrophic obstructive cardiomyopathy.docx by Anselm A. Derda (5866220)

    Published 2024
    “…</p>Results<p>16 patients discontinued their afterload-reducing drugs, resulting in a significant decrease in median LVOT gradient from 86.5 [60.5–109.3] mmHg to 61.5 [28.3–97.50] mmHg (p = 0.0004). …”